Publications by authors named "Evandro Azambuja"

Claim this Profile
C
Characteristics, Treatment Patterns and Clinical Outcomes of Women with Maghreb Origin and Diagnosis of Breast Cancer: A Single-Center, Retrospective Cohort Study.
Chiara Dauccia, Diogo Martins-Branco, Michel Moreau, Lieveke Ameye, Elisa Agostinetto, Evandro de Azambuja

Clin Breast Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population.
Lucas F van Schaik, Brigitte Maes, Pieter-Jan Volders, Guy Froyen, Philippe Aftimos, Evandro de Azambuja

JAMA Netw Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.
Evert S M van Aken, Ajeet Kumar Gandhi, Sean M O'Cathail, Gerben Borst, Jorge Barriuso, Evandro de Azambuja

Radiother Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives.
Luca Arecco, Gabriella Gentile, Riccardo Gerosa, Matteo Lambertini, Laurence Buisseret, Evandro de Azambuja

Curr Opin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.
Soraia Lobo-Martins, Veronique Debien, Elisa Agostinetto, Marianna Sirico, Giselle de Souza Carvalho, Evandro de Azambuja

Clin Breast Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of statin use on survival outcomes of patients with early-stage HER2-positive breast cancer in the APHINITY trial.
Christian Maurer, Elisa Agostinetto, Lieveke Ameye, Matteo Lambertini, Samuel Martel, Evandro de Azambuja

Breast Cancer Res Treat· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic implications of risk definitions from the monarchE and NATALEE trials.
Luca Arecco, Eva Blondeaux, Marco Bruzzone, Grazia Arpino, Carmine De Angelis, Evandro de Azambuja

J Natl Cancer Inst· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting.
Karin Jordan, Evandro de Azambuja, María Ángeles García Del Barrio, Franziska Jahn, Mario Di Palma

Eur J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Venkataraman and Mokbel.
Luca Arecco, Eva Blondeaux, Elisa Agostinetto, Evandro De Azambuja, Matteo Lambertini

J Natl Cancer Inst· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index and weight changes in patients with HER2-positive early breast cancer: A sub-analysis of the APHINITY trial.
Chiara Dauccia, Maria Alice Franzoi, Samuel Martel, Dominique Agbor-Tarh, Shona Fielding, Evandro de Azambuja

Eur J Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.
Karen Van Baelen, Ha-Linh Nguyen, François Richard, Gitte Zels, Maria Margarete Karsten, Evandro de Azambuja

Breast Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of margin distance on recurrence and survival following breast-conserving surgery after neoadjuvant systemic therapy.
C Florin Pop, Clémence Ortega, Mathilde Lecomte, Paulus Kristanto, Chirine Khaled, Evandro De Azambuja

NPJ Breast Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Challenge of Calculating EUSOMA Quality Indicators with Administrative Data: A Pilot Study in Belgium.
Roos Leroy, Cindy De Gendt, Jolyce Bourgeois, Julie Verbeeck, Isabelle Savoye, Evandro de Azambuja

Breast Care (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer.
Pieter-Jan Volders, Philippe Aftimos, Franceska Dedeurwaerdere, Geert Martens, Jean-Luc Canon, Evandro de Azambuja

NPJ Precis Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Dietary Supplements on Clinical Outcomes and Quality of Life in Patients with Breast Cancer: A Systematic Review.
Luca Scafuri, Carlo Buonerba, Oriana Strianese, Evandro de Azambuja, Michela Palleschi

Nutrients· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer.
Marc P Bonaca, Ninian N Lang, Alice Chen, Laleh Amiri-Kordestani, Leslie Lipka, Evandro de Azambuja

JACC CardioOncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter "re: Surgery of the primary tumor in patients with de novo metastatic breast cancer: A nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB)".
Diogo Martins-Branco, Mariana Brandão, Evandro de Azambuja

Breast Cancer Res Treat· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer.
Volkmar Müller, Thomas Bachelot, Giuseppe Curigliano, Evandro de Azambuja, Julia Furtner

Cancer Treat Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter entitled: Re: Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in Belgium.
Roos Leroy, Jolyce Bourgeois, Jean-Luc Canon, Birgit Carly, Evandro de Azambuja

Eur J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.
Michail Ignatiadis, Andrew Bailey, Heather McArthur, Sarra El-Abed, Evandro de Azambuja

JAMA· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond" [Crit. Rev. Oncol./Hematol. 200C (2024) 104404].
M Sirico, F Jacobs, C Molinelli, Guilherme Nader-Marta, V Debien, Evandro de Azambuja

Crit Rev Oncol Hematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.
Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric Winer, Evandro de Azambuja

J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-drug conjugates in patients with advanced/metastatic HER2-low-expressing breast cancer: a systematic review and meta-analysis.
Isabella Michelon, Maria Inez Dacoregio, Maysa Vilbert, Jonathan Priantti, Caio Ernesto do Rego Castro, Evandro de Azambuja

Ther Adv Med Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in Belgium.
Roos Leroy, Geert Silversmit, Jolyce Bourgeois, Cindy De Gendt, Isabelle Savoye, Evandro de Azambuja

Eur J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109).
Guilherme Nader-Marta, Christian Singer, Dominik Hlauschek, Angela DeMichele, Paolo Tarantino, Evandro de Azambuja

Breast Cancer Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis